S-adenosylmethionine: A control switch that regulates liver function

FASEB Journal

Volumn 16, Issue 1, 2002, Pages 15-26

  Mato, José M ^a   Corrales, Fernando J ^a   Lu, Shelly C ^a,b   Avila, Matías A ^a  

^a UNIVERSITY OF NAVARRA   (Spain)

^b UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

Gene expression; Hepatocyte proliferation; Knockout mouse; Liver injury

Indexed keywords

S ADENOSYLMETHIONINE;

DIET SUPPLEMENTATION; DRUG MECHANISM; DRUG USE; GENE EXPRESSION REGULATION; GENE SEQUENCE; GENE THERAPY; HUMAN; LIVER DISEASE; LIVER FUNCTION; METHYLATION; NONHUMAN; NUTRITIONAL SUPPORT; PRIORITY JOURNAL; REVIEW; SIGNAL TRANSDUCTION;

ANIMALS; CELL DIFFERENTIATION; CELL DIVISION; DISEASE MODELS, ANIMAL; HUMANS; LIVER; LIVER DISEASES; METHIONINE ADENOSYLTRANSFERASE; MICE; MODELS, BIOLOGICAL; PROTEIN PROCESSING, POST-TRANSLATIONAL; S-ADENOSYLMETHIONINE;

CAESALPINIA CILIATA; MAMMALIA;

EID: 0036136732     PISSN: 08926638     EISSN: None     Source Type: Journal    
DOI: 10.1096/fj.01-0401rev     Document Type: Review

References (96)

1. Biochemical methylations: Selected aspects
2. 1,4-Diaminobutane (putrescine), spermidine and spermine
3. Homocysteine: A history in progress
4. Rate of disappearance from plasma of intravenously administered methionine in patients with liver damage
5. Labile methyl balances for normal humans of various dietary regimens
6. Methionine metabolism in mammals
7. Activation of cystathionine synthase by S-adenosylmethionine and S-adenosylmethionine
8. Inactivation of betaine-homocysteine methyltransferase by S-adenosylmethionine and S-adenosylhomocysteine
9. Methionine metabolism in mammals: Distribution of homocysteine between competitive pathways
10. Feedback inhibition of methylene-tetrahydrofolate reductase in rat liver by S-adenosylmethionine
11. Mammalian methylene-tetrahydrofolate reductase: Partial purification, properties and inhibition by S-adenosylmethionine
12. Consensus nomenclature for the mammalian methionine adenosyltransferase genes and gene products
13. Activation of methionine for transmethylation. The mechanism of action of the methionine-activating enzyme
14. S-adenosylmethionine synthetase from Escherichia coli
15. S-Adenosylmethionine synthesis: Molecular mechanisms and clinical implications
16. Analysis of the 5′ non-coding region of rat liver S-adenosylmethionine synthetase mRNA and comparison of the Mdeduced from the cDNA sequence and the purified enzyme
17. Crystal structure of S-adenosylmethionine synthetase
18. The crystal structure of tetrameric methionine adenosyltransferase from rat liver reveals the methionine-binding site
19. Biochemical basis for the dominant inheritance of hypermethioninemia associated with the R264H mutation of the MAT1A gene. A monomeric methionine adenosyltransferase with tripolyphosphatase activity
20. Flexible loop in the structure of S-adenosylmethionine synthetase crystallized in the tetragonal modification
21. Methionine adenosyltransferase S-nitrosylation is regulated by the basic and acidic amino acids surrounding the target thiol
22. Methionine adenosyltransferase: Structure and function
23. Differential expression pattern of S-adenosylmethionine synthetase isoenzymes during rat liver development
24. Cloning, expression, and functional characterization of the β regulatory subunit of human methionine adenosyltransferase (MAT II)
25. A novel NDP-6-deoxyhexosyl-4-ulose reductase in the pathway for the synthesis of thymidine diphosphate-D-fucose
26. Expression and functional interaction of the catalytic and regulatory subunits of human methionine adenosyltransferase in mammalian cells
27. Differential regulation of methionine adenosyltransferase in superantigen and mitogen stimulated human T lymphocytes
28. Differential expression of S-adenosyl-methionine synthetase isoenzymes in different cell types of rat liver
29. Hysteretic behavior of methionine adenosyltransferase III. Methionine switches between two conformations of the enzyme with different specific activity
30. Modulation of rat liver S-adenosylmethionine synthetase activity by glutathione
31. Glycine N-methyltransferase: Structure and function
32. Glycine N-methyltransferase deficiency: A novel inborn error causing persistent isolated hypermethioninemia
33. Regulation of rat liver S-adenosylmethionine synthetase during septic shock: Role of nitric oxide
34. Regulation by hypoxia of methionine adenosyltransferase activity and gene expression in rat hepatocytes
35. Increased sensitivity to oxidative injury in chinese hamster ovary cells stably transfected with rat liver S-adenosylmethionine synthetase cDNA
36. Interaction of liver methionine adenosylltransferase with hydroxyl radical
37. (S)NO signals: Translocation regulation, and a consensus motif
38. Creation of a functional S-anitrosylation site in vitro by single point mutation
39. Nitric oxide inactivates rat hepatic methionine adenosyltransferase in vivo by S-nitrosylation
40. In vivo regulation by glutathione of methionine adenosyltransferase S-nistrosylation in rat liver
41. S-adenosylmethionine synthetase and phospholipid methyltransferase are inhibited in human cirrhosis
42. Specific loss of the high molecular weight form of S-adenosylmethionine synthetase in human liver cirrhosis
43. Changes in methionine adenosyltransferase and S-adenosylmethionine homeostasis in alcoholic rat liver
44. Structure of the rat methionine adenosyltransferase 2A gene and its promoter
45. Regulation of the human MAT2B gene encoding the regulatory beta subunit of methionine adenosyltransferase, MAT II
46. Characterization of rat liver-specific methionine adenosyltransferase gene promoter. Role of distal upstream cis-acting elements in the regulation of the transcription activity
47. Cloning and functional characterization of the 5′-flanking region of human methionine adenosyltransferase 2A gene
48. Cloning and functional characterization of the 5′-flanking region of human methionine adenosyltransferase 1A gene
49. Glucocorticoid regulation of hepatic S-adenosylmethionine synthetase gene expression
50. Liver-specific methionine adenosyltransferase MAT1A gene expression is associated with a specific pattern of promoter methylation and histone acetylation: Implications for MAT1A silencing during transformation
51. DNA methylation and histone acetylation of rat methionine adenosyltransferase 1A and 2A genes is tissue-specific
52. DNA methylation
53. Signaling to chromatin through histone modifications
54. Changes in S-adenosylmethionine synthetase in human liver cancer: Molecular characterization and significance
55. Reduced mRNA abundance of the main enzymes involved in methionine metabolism in human liver cirrhosis and hepatocellular carcinoma
56. Evidence for impairment of transsulfuration pathway in cirrhosis
57. Methyl groups in the regulation of MAT1A and MAT2A gene expression
58. Role of promoter methylation in increased methionine adenosyttransferase 2A expression in human liver cancer
59. Hepatocyte growth factor induces MAT2A expression and histone acetylation in rat hepatocytes: Role in liver regeneration
60. The role of c-Myb and Spl in the up-regulation of methionine adenosyltransferase 2A gene expression in human hepatocellular carcinoma
61. The role of c-Myb in the up-regulation of methionine adenosyltransferase 2A expression in activated Jurkat cells
62. Liver regeneration
63. Changes in methionine adenosyltransferase during liver regeneration in the rat
64. S-Adenosylmethionine regulates MAT1A and MAT2A gene expression in cultured rat hepatocytes: A new role for S-adenosylmethionine in the maintenance of the differentiated status of the liver
65. Differential expression of methionine adenosyltransferase genes influences the rate of growth of human hepatocellular carcinoma cells
66. The ins and outs of signalling
67. CDK inhibitors: Positive and negative regulators of G1-phase progression
68. Regulation of cyclin D-dependent kinase activity in rat liver regeneration
69. Cyclin D1 promotes mitogen-independent cell-cycle progression in hepatocytes
70. Molecular mechanisms underlying ErbB2/HER2 action in breast cancer
71. Inhibition of promotion and persistent nodule growth by S-adenosyl-L-methionine in rat liver carcinogenesis: Role of remodeling and apoptosis
72. Chemoprevention of rat liver carcinogenesis by S-adenosylmethionine: A long-term study
73. Methionine adenosyltransferase 1A knockout mice are predisposed to liver injury and exhibit increased expression of genes involved in proliferation
74. Hepatic hyperplasia in noncirrhotic fatty livers: Is obesity-related hepatic steatosis a premalignant condition?
75. Impaired liver regeneration in inducible nitric oxide synthase-deficient mice
76. The effect of lecithin on fat deposition in the liver of the normal rat
77. Lipotropic factors and oncogenesis
78. Tissue levels of S-adenosylmethionine and S-adenosylhomocysteine in rats fed methyl-deficient, amino acid-defined diets for one to five weeks
79. Effect of dietary methyl group deficiency on one-carbon metabolism in rats
80. Cytochrome P-4502E: Its physiological and pathological role
81. Alcohol: Its metabolism and interaction with nutrients
82. Current concepts in the pathogenesis of alcoholic liver injury
83. Nonalcoholic steatohepatitis
84. Stable transfection of human cytochrome P4502E1 in HepG2 cells: Characterization of catalytic activities and production of reactive oxygen intermediates
85. Ethanol citotoxicity to a transfected HepG2 cell line expressing human cytochrome P4502E1
86. Modulation of experimental alcohol-induced liver disease by cytochrome P4502E1 inhibitors
87. CYP2E1 is not involved in early alcohol-induced liver injury
88. CYP2E1 and CYP4A as microsomal catalysts of lipid peroxides in murine nonalcoholic steatohepatitis
89. Hepatic cytochrome P4502E1 is increased in patients with nonalcoholic steatohepatitis
90. Altered expression of hepatic CYP2E1 and CYP4A in obese, diabetic ob/ob mice and fa/fa Zucker rats
91. Regulation of hepatic glutathione synthesis: Current concepts and controversies
92. CYP2E1 overexpression in HepG2 cells induces glutathione synthesis by transcriptional activation of γ-glutamylcysteine synthetase
93. Molecular genetics of hepatic methionine adenosyltransferase deficiency
94. Role of S-adenosylmethionine in the treatment of liver diseases
95. S-Adenosylmethionine in alcoholic liver cirrhosis: A randomized, placebo-controlled, double-blind, multicenter clinical trial